C. Cadoni et G. Di Chiara, Reciprocal changes in dopamine responsiveness in the nucleus accumbens shell and core and in the dorsal caudate-putamen in rats sensitized to morphine, NEUROSCIENC, 90(2), 1999, pp. 447-455
In this study, we describe a model of opiate sensitization characterized by
a brief schedule of treatment with repeated morphine administrations. In t
his model, we investigated the changes produced by repealed morphine treatm
ent on dopamine transmission at the level of the two major terminal dopamin
ergic areas, the dorsolateral caudate-putamen and the nucleus accumbens in
its two subdivisions, the shell and the core. Rats were treated twice a day
for three days with increasing doses of morphine (10, 20 and 40 mg/kg, s.c
.) or with saline. After 15 days of withdrawal, rats were challenged with 1
and 5 mg/kg (s.c.) of morphine, and dopamine transmission was monitored by
microdialysis. In this model, we show that repeated morphine produces a st
rong behavioral sensitization accompained by increased stimulation of dopam
ine transmission in the core of the nucleus accumbens and in the caudate-pu
tamen, and by a decreased stimulation of dopamine transmission in the shell
of the nucleus accumbens, as compared to control rats. Moreover, we admini
stered to these animals amphetamine (0.5 mg/kg, s.c.) and cocaine (10 mg/kg
, i.p.) to assess whether cross-sensitization occurs between opiates and ps
ychostimulants in conditions independent of the context. In the present stu
dy, we did not observe either behavioral or biochemical sensitization to am
phetamine and to cocaine in rats sensitized to morphine.
These results suggest that rats behaviorally sensitized to morphine show op
posite changes in the stimulant effect of morphine in the nucleus accumbens
shell and core and in the dorsal caudate-putamen, Moreover, this study sug
gests that sensitization of the dopamine system to a given agent does not n
ecessarily extend to drugs of abuse of different pharmacological classes. (
C) 1999 IBRO. Published by Elsevier Science Ltd.